These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16650735)

  • 1. Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome.
    Rosen JL; Miller TJ; D'Andrea JT; McGlashan TH; Woods SW
    Schizophr Res; 2006 Jul; 85(1-3):124-31. PubMed ID: 16650735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cannabis and schizophrenia: demographic and clinical correlates].
    Dervaux A; Laqueille X; Bourdel MC; Leborgne MH; Olié JP; Lôo H; Krebs MO
    Encephale; 2003; 29(1):11-7. PubMed ID: 12640322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics influencing age at onset in psychotic disorders.
    Ongür D; Lin L; Cohen BM
    Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
    Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
    Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depression: the relative contribution of gender, MDMA, and cannabis use.
    Durdle H; Lundahl LH; Johanson CE; Tancer M
    Depress Anxiety; 2008; 25(3):241-7. PubMed ID: 17345601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.
    Dubertret C; Bidard I; Adès J; Gorwood P
    Schizophr Res; 2006 Sep; 86(1-3):284-90. PubMed ID: 16806837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective quality of life in first episode schizophrenia spectrum disorders with comorbid depression.
    Sim K; Mahendran R; Siris SG; Heckers S; Chong SA
    Psychiatry Res; 2004 Dec; 129(2):141-7. PubMed ID: 15590041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia.
    Dervaux A; Goldberger C; Gourion D; Bourdel MC; Laqueille X; Lôo H; Olié JP; Krebs MO
    Schizophr Res; 2010 Nov; 123(2-3):278-80. PubMed ID: 20832995
    [No Abstract]   [Full Text] [Related]  

  • 10. Depression and depressive symptoms in first episode psychosis.
    Romm KL; Rossberg JI; Berg AO; Barrett EA; Faerden A; Agartz I; Andreassen OA; Melle I
    J Nerv Ment Dis; 2010 Jan; 198(1):67-71. PubMed ID: 20061872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early course of schizophrenia in a representative Dutch incidence cohort.
    Selten JP; Veen ND; Hoek HW; Laan W; Schols D; van der Tweel I; Feller W; Kahn RS
    Schizophr Res; 2007 Dec; 97(1-3):79-87. PubMed ID: 17683911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders.
    Sevy S; Burdick KE; Visweswaraiah H; Abdelmessih S; Lukin M; Yechiam E; Bechara A
    Schizophr Res; 2007 May; 92(1-3):74-84. PubMed ID: 17379482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.
    Foti DJ; Kotov R; Guey LT; Bromet EJ
    Am J Psychiatry; 2010 Aug; 167(8):987-93. PubMed ID: 20478874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid diagnoses for youth at clinical high risk of psychosis.
    Addington J; Piskulic D; Liu L; Lockwood J; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Bearden CE; Mathalon DH; Woods SW
    Schizophr Res; 2017 Dec; 190():90-95. PubMed ID: 28372906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is cannabis a vulnerability factor in schizophrenic disorders].
    Laqueille X
    Arch Pediatr; 2009 Sep; 16(9):1302-5. PubMed ID: 19640690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.